Related Experiment Video
Updated: Jun 11, 2025
Setting a Successful Sorting for Extracellular Vesicle Isolation
Published on: October 11, 2024
Therapeutic Potential of Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying MicroRNAs for Modulating
LinFeng Wang1, Yang Wang, Jianhang Jiao
1Department of Orthopedics, The Second Hospital of Jilin University, Changchun, Jilin, China.
Study Design:
This research utilized bioinformatics and in vitro modeling to assess the effects of mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) containing specific microRNAs (miRNAs) on the autophagy and degeneration of nucleus pulposus cells in intervertebral disc degeneration (IDD).
Objective:
To determine the therapeutic potential of MSC-EVs loaded with miRNAs in modulating pathologic changes in IDD.
Background:
IDD is characterized by changes in gene expression that contribute to cell degeneration and reduced disc integrity. MSC-EVs are known for their role in cellular communication and potentially reversing these degenerative processes.
Materials And Methods:
Key differentially expressed miRNAs and mRNAs in MSC-EVs were identified using bioinformatics analysis. Three miRNAs (miR-486-5p, miR-3648, and miR-1827) typically downregulated in IDD were selected for further study. The bone marrow-derived MSC-EVs used in this study were cultured in a two-dimensional environment. These MSC-EVs were isolated with the purpose of delivering the selected miRNAs to IDD nucleus pulposus cells in vitro, targeting specifically the upregulated genes ( SMAD2 , ESR1 , MAVS , and MMP14 ) associated with autophagy and degeneration.
Results:
MSC-EV treatment led to significant downregulation of target genes, enhanced cellular proliferation, and decreased apoptosis and autophagy. Overexpression of these target genes produced the opposite effects, confirming the miRNAs' regulatory roles.
Conclusions:
MSC-EVs carrying specific miRNAs can effectively modulate gene expression, reduce degenerative processes, and promote cellular proliferation in IDD, indicating a promising therapeutic strategy for treating IDD and potentially other degenerative diseases. Further investigations are warranted to explore MSC-EV applications in regenerative medicine.
